Author

Yifat S. Oren

Hebrew University of JerusalemORCID 0000-0002-1511-8162Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anita GoleciD· 1 shared Aurélie HattoniD· 1 shared Batsheva KeremiD· 1 shared Chen LeibsoniD· 1 shared Efrat Ozeri-GalaiiD· 1 shared Eitan KeremiD· 1 shared Eric J. SorscheriD· 1 shared Isabelle Sermet‐GaudelusiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Anita GolecORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsJournal of Cystic FibrosisPeer-reviewedJul 2, 2021

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

Yifat S. Oren, Michal Irony‐Tur Sinai, Anita Golec…·Batsheva Kerem

This study develops an antisense oligonucleotide (ASO) therapy for CF patients with the 3849+10kb C-to-T splicing mutation, showing restoration of CFTR function in patient-derived cells.

55 citationstop 2%

humanexperimental assay

𝕏 PostBluesky